Global Competent E.coli Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Competent E.coli Market Insights, Forecast to 2034
Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass through more easily. Such cells are said to be "competent."
Global Competent E.coli market is expected to reach to US$ 120 million in 2023, with a positive growth of %, compared with US$ 115 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Competent E.coli industry is evaluated to reach US$ 151.8 million in 2033. The CAGR will be 4.0% during 2023 to 2033.
Globally, Competent E.coli key manufacturers include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. Thermo Fisher Scientific Inc, Promega, Merck KGaA are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Competent E.coli were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Competent E.coli market and estimated to attract more attentions from industry insiders and investors.
Competent E.coli can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Competent E.coli is widely used in various fields, such as Molecular Cloning, Plasmid Extraction and Other,, etc. Molecular Cloning provides greatest supports to the Competent E.coli industry development. In 2022, global % sales of Competent E.coli went into Molecular Cloning filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Competent E.coli market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Competent E.coli market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Molecular Cloning
Plasmid Extraction
Other
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Competent E.coli plant distribution, commercial date of Competent E.coli, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Competent E.coli introduction, etc. Competent E.coli Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Competent E.coli
Chapter 15Methodology and Data Sources adopted by MRAResearch
Global Competent E.coli market is expected to reach to US$ 120 million in 2023, with a positive growth of %, compared with US$ 115 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Competent E.coli industry is evaluated to reach US$ 151.8 million in 2033. The CAGR will be 4.0% during 2023 to 2033.
Globally, Competent E.coli key manufacturers include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. Thermo Fisher Scientific Inc, Promega, Merck KGaA are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Competent E.coli were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Competent E.coli market and estimated to attract more attentions from industry insiders and investors.
Competent E.coli can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Competent E.coli is widely used in various fields, such as Molecular Cloning, Plasmid Extraction and Other,, etc. Molecular Cloning provides greatest supports to the Competent E.coli industry development. In 2022, global % sales of Competent E.coli went into Molecular Cloning filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Competent E.coli market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Competent E.coli market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Molecular Cloning
Plasmid Extraction
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Competent E.coli plant distribution, commercial date of Competent E.coli, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Competent E.coli introduction, etc. Competent E.coli Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Competent E.coli
Chapter 15Methodology and Data Sources adopted by MRAResearch